known
human
coronavirus
hcov
usual
caus
mild
moder
upperrespiratori
tract
ill
except
sarscov
merscov
addit
mild
ill
also
associ
sever
respiratori
diseas
high
mortal
rate
wellcharacter
multiplex
serolog
assay
need
aid
rapid
detect
surveil
hcov
present
studi
describ
develop
evalu
multiplex
magnet
microspher
immunoassay
mmia
simultan
detect
immunoglobulin
g
igg
antibodi
specif
recombin
nucleocapsid
protein
recn
hcov
sarscov
merscov
use
pair
human
sera
screen
igg
reactiv
six
hcov
determin
assay
sensit
specif
reproduc
found
signal
interfer
monoplex
multiplex
assay
format
r
rang
screen
pair
human
sera
use
mmia
result
sensit
posit
specif
neg
studi
serv
proof
concept
feasibl
develop
use
multiplex
microspher
immunoassay
next
gener
screen
tool
use
larg
scale
seropreval
studi
hcov
coronavirus
cov
belong
coronavirida
famili
order
nidoviral
singlestrand
positivesens
rna
virus
outer
envelop
crownlik
morpholog
form
spike
attach
glycoprotein
base
phylogenet
analysi
cov
classifi
four
genera
alpha
beta
gamma
deltacoronaviru
current
six
strain
human
coronavirus
hcov
known
caus
mild
sever
upper
lower
respiratori
tract
infect
human
earli
earli
two
hcov
known
caus
infect
human
alphacoronaviru
betacoronaviru
outbreak
sever
acut
respiratori
syndrom
sar
cov
betacoronaviru
origin
guangdong
provinc
china
result
report
case
death
worldwid
follow
outbreak
alphacoronaviru
betacoronaviru
identifi
sourc
upper
respiratori
gastrointestin
tract
infect
hospit
patient
recent
merscov
middl
east
respiratori
syndrom
coronaviru
identifi
etiolog
agent
ongo
epidem
sever
respiratori
infect
high
mortal
rate
middl
east
vaccin
antivir
approv
treatment
prevent
infect
caus
sarscov
merscov
absenc
virusspecif
control
measur
key
control
reemerg
sarscov
spread
merscov
rapid
detect
isol
suspect
case
larg
scale
populationbas
seropreval
studi
use
identif
critic
control
point
diseas
outbreak
provid
import
data
suscept
popul
potenti
futur
outbreak
predict
model
use
purifi
recombin
viral
antigen
base
enzymelink
immunosorb
assay
elisa
publish
xx
xx
xxxx
open
wwwnaturecomscientificreport
coupl
molecular
detect
assay
effect
approach
popul
base
surveil
studi
develop
valid
hcov
recombin
nucleocapsid
protein
recn
indirect
elisa
individu
detect
immunoglobulin
g
igg
antibodi
six
hcov
hcov
nucleocapsid
n
protein
abundantli
express
infect
therefor
one
ideal
candid
antigen
develop
microtit
plate
base
elisa
howev
tradit
plate
elisa
limit
detect
igg
antibodi
singl
hcov
recn
antigen
per
well
contrast
magnet
beadbas
multiplex
immunoassay
mmia
would
allow
simultan
detect
igg
antibodi
six
hcov
recn
singl
test
well
reduc
sampl
consumpt
addit
multiplex
would
allow
higher
sampl
throughput
lower
reagent
labor
materi
cost
without
lose
sensit
specif
tradit
elisa
present
work
describ
develop
valid
mmia
detect
human
serum
igg
six
hcov
recn
next
gener
screen
tool
populationbas
seropreval
studi
titrat
antigen
concentr
monoplex
assay
hcov
recn
conjug
bead
set
develop
standard
determin
optimum
antigen
quantiti
per
bead
coupl
reaction
optimum
serum
dilut
assay
cutoff
mean
fluoresc
intens
mfi
valu
bead
set
conjug
antigen
per
conjug
reaction
bead
checkerboard
titrat
assay
carri
antigen
seri
posit
neg
control
sera
optimum
work
antigen
amount
determin
sarscov
recn
hisbont
recn
recn
merscov
recn
pet
e
coli
recn
per
conjug
reaction
bead
fig
base
posit
serum
control
titrat
result
optimum
dilut
antigen
determin
sarscov
merscov
fig
optimum
antigen
quantiti
posit
control
serum
dilut
select
base
highest
signal
background
ratio
reproduc
result
econom
usag
antigen
stock
correl
monoplex
multiplex
assay
compar
mfi
valu
gener
monoplex
assay
multiplex
assay
antigen
investig
possibl
loss
sensit
due
drop
mfi
valu
posit
control
serum
pool
hcov
serial
dilut
dilut
screen
use
monoplex
multiplex
microspher
immunoassay
assay
format
bead
bead
duplic
count
recn
conjug
bead
set
linear
regress
analysi
perform
determin
correl
coeffici
recn
antigen
recn
bead
set
statist
signific
correl
observ
monoplex
multiplex
format
correl
coeffici
r
rang
fig
determin
sensit
specif
cutoff
mfi
valu
antigen
receiv
oper
characterist
roc
analysi
carri
base
screen
human
sera
collect
individu
whose
respiratori
specimen
test
revers
real
time
polymeras
chain
reaction
rrtpcr
presenc
absenc
hcov
infect
acut
convalesc
phase
sera
individu
test
posit
hcov
infect
well
convalesc
phase
sera
confirm
posit
infect
merscov
sarscov
screen
use
mmia
addit
pair
sera
individu
test
neg
hcov
infect
also
screen
use
mmia
percentag
sensit
se
specif
sp
recn
estim
wide
rang
cutoff
mfi
valu
plot
two
graph
receiv
oper
characterist
curv
tgroc
use
spss
softwar
data
shown
mfi
valu
pair
valu
se
sp
optim
intersect
se
sp
graph
line
select
cutoff
mfi
respect
recn
antigen
data
shown
cutoff
mfi
valu
select
sarscov
merscov
recn
monoplex
assay
respect
correspond
sensit
specif
valu
describ
tabl
determin
overal
assay
perform
mmia
area
curv
auc
calcul
six
hcov
recn
use
rtpcr
refer
diagnost
test
fig
calcul
auc
valu
sarscov
merscov
recn
respect
fig
indic
moder
high
level
test
accuraci
assess
reproduc
mmia
panel
posit
control
serum
sampl
hcov
run
duplic
optimum
serum
dilut
two
differ
plate
day
repeat
new
batch
conjug
bead
differ
day
coeffici
variat
cv
replic
antigen
calcul
averag
tabl
assay
except
recn
gave
cv
valu
indic
mmia
precis
crossreact
recn
antigen
examin
cross
reactiv
hcov
recn
human
sera
screen
posit
control
hcov
multiplex
format
dilut
rang
result
show
overal
minimum
cross
reactiv
amongst
hcov
recn
fig
howev
posit
control
hcov
antigen
group
show
cross
reactiv
posit
control
group
alpha
human
coronavirus
show
reactiv
group
hcov
howev
sarscov
group
posit
control
serum
react
group
cov
posit
control
serum
group
beta
coronaviru
react
recn
anoth
member
group
wherea
posit
control
merscov
group
react
recn
use
beadbas
multiplex
immunoassay
technolog
gain
recognit
next
gener
screen
tool
seropreval
studi
sever
research
group
report
develop
beadbas
multiplex
immunoassay
detect
antibodi
varieti
human
viral
pathogen
duplex
assay
develop
detect
igg
recombin
nucleocapsid
protein
human
respiratori
syncyti
viru
hrsv
human
metapneumoviru
hmpv
quadruplex
assay
develop
detect
igg
measl
mump
rubella
varicellazost
viru
thirteenplex
immunoassay
develop
detect
igm
igg
serodetect
arbovirus
result
current
studi
show
feasibl
use
multiplex
bead
immunoassay
screen
human
sera
igg
six
human
coronaviru
recombin
nucleocapsid
protein
use
roc
analysi
studi
facilit
select
optim
mfi
cutoff
valu
also
help
determin
accuraci
use
test
method
calcul
area
roc
curv
perfect
test
auc
useless
test
area
equival
coin
toss
base
arbitrari
criteria
follow
guidelin
suggest
interpret
auc
valu
context
test
accuraci
low
auc
moder
auc
high
auc
base
assay
test
result
calcul
auc
rang
suggest
high
highmoder
level
accuraci
overal
assay
perform
cross
reactiv
experi
result
show
posit
control
sarscov
react
group
hcov
recn
major
limit
assay
unabl
distinguish
differ
cross
reactiv
evid
previou
infect
sarscov
recn
shown
react
polyclon
antisera
group
coronavirus
western
blot
analysi
howev
cross
reactiv
oneway
sarscov
hcov
recn
studi
also
previous
confirm
che
et
al
separ
studi
multipl
sequenc
ident
matrix
hcov
nucleocapsid
protein
sequenc
show
amino
acid
homolog
rang
data
shown
contrast
group
hcov
show
sequenc
homolog
group
hcov
explain
lack
detect
crossreact
two
antigen
group
howev
sequenc
homolog
high
nucleocapsid
sequenc
merscov
higher
percentag
nucleocapsid
protein
sequenc
homolog
may
indic
share
epitop
conserv
andor
overlap
region
hcov
antigen
group
sinc
previou
hcov
infect
histori
patient
enrol
studi
unavail
dual
infect
could
also
contribut
crossreact
though
unlik
merscov
hcov
mmia
offer
high
throughput
test
reduc
cost
assay
complet
less
time
less
labor
use
less
clinic
specimen
assay
reagent
moreov
mmia
allow
flexibl
mix
match
bead
set
depend
upon
analysi
requir
overal
result
studi
show
develop
beadbas
multiplex
immunoassay
screen
human
sera
igg
antibodi
hcov
recn
protein
feasibl
may
serv
effect
tool
larg
scale
seropreval
studi
examin
preval
hcov
young
children
differ
age
human
serum
sampl
method
carri
accord
cdc
institut
review
board
irb
guidelin
regul
protocol
approv
cdc
irb
patient
hospit
pneumonia
symptom
gave
inform
consent
respiratori
specimen
test
rrtpcr
determin
etiolog
pair
acut
convalesc
phase
human
sera
collect
individu
whose
respiratori
specimen
test
posit
n
n
n
n
rrtpcr
includ
posit
control
panel
studi
human
sera
patient
confirm
sarscov
n
merscov
infect
n
test
outbreak
investig
laboratori
also
includ
posit
control
panel
acut
sera
collect
upon
hospit
admiss
convalesc
phase
sera
obtain
week
later
panel
posit
sera
convalesc
phase
sera
exhibit
fold
increas
igg
titer
pool
togeth
creat
posit
control
hcov
recn
similarli
acut
convalesc
phase
human
sera
collect
individu
acut
respiratori
ill
whose
respiratori
specimen
test
neg
six
hcov
realtim
rtpcr
exhibit
igg
reactiv
screen
inhous
hcov
recn
enzym
immunoassay
includ
creat
neg
control
panel
use
recombin
coronaviru
nucleocapsid
n
protein
n
antigen
full
length
sarscov
recn
neg
control
antigen
nontox
ctermin
fragment
botulinum
neurotoxin
serotyp
bonthca
express
purifi
describ
previous
express
purif
full
length
recn
recn
recn
merscov
recn
purifi
protein
e
coli
contain
vector
without
n
gene
neg
antigen
control
carri
describ
previous
control
well
n
subtract
divid
od
valu
antigenco
well
p
averag
od
valu
antigenco
well
calcul
differ
pn
ratio
pn
purifi
histag
whole
truncat
recn
sarscov
merscov
along
pet
e
coli
hisbont
neg
antigen
control
coval
conjug
eight
spectral
distinct
magplex
promagnet
microspher
bead
set
luminex
corpor
austin
tx
use
two
step
carbodiimid
coupl
protocol
provid
bioplex
amin
coupl
kit
biorad
laboratori
hercul
ca
wash
step
perform
use
magnet
separ
luminex
bead
vortex
vigor
recn
multiplex
immunoassay
recn
conjug
bead
brought
room
temperatur
prior
perform
multiplex
immunoassay
bead
vortex
sec
sonic
water
bath
sonic
branson
ultrason
cleaner
vwr
intern
west
chester
pa
sec
prepar
work
dilut
bead
set
dilut
pb
ph
final
concentr
pb
dilut
bead
set
mix
singl
ml
polypropylen
centrifug
tube
equal
quantiti
ml
centrifug
tube
vortex
sonic
describ
creat
homogen
mixtur
conjug
bead
set
test
sera
dilut
optim
dilut
test
duplic
perform
multiplex
bead
immunoassay
homogen
mixtur
conjug
bead
dilut
test
serum
sampl
pb
ph
ad
well
plate
rest
assay
carri
use
step
describ
monoplex
assay
except
result
express
mfi
beadsregionwel
assay
sensit
specif
panel
posit
pair
sera
neg
pair
sera
individu
confirm
hcov
infect
test
use
multiplex
microspher
immunoassay
mmia
use
rrtpcr
refer
test
sensit
se
specif
sp
mmia
calcul
plot
two
graph
receiv
oper
characterist
tgroc
analysi
plot
intersect
se
sp
plot
select
cutoff
mfi
recn
result
also
plot
roc
curv
area
curv
auc
calcul
recn
determin
overal
assay
perform
assay
reproduc
correl
coeffici
seri
dilut
posit
neg
control
six
hcov
prepar
surmod
assay
diluent
cat
surmod
mn
test
use
monoplex
multiplex
immunoassay
format
determin
correl
two
format
panel
use
multiplex
format
determin
crossreact
hcov
recn
bead
well
within
assay
variat
sampl
panel
run
triplic
two
differ
plate
trial
repeat
seven
day
use
anoth
set
conjug
bead
scientif
report
http
statist
analysi
ibm
spss
statist
softwar
use
perform
receiveroper
characterist
roc
area
curv
auc
assay
cutoff
analysi
linear
regress
analysi
perform
use
excel
microsoft
offic
determin
correl
coeffici
coeffici
varianc
antigen
raw
data
made
avail
upon
request
author
also
agre
share
reagent
use
manuscript
